Park Grove IP is a patent attorney firm that provides expert advice to companies in the chemical, pharmaceutical and life sciences fields. The owner of the firm, Mike Snodin, has a Masters degree and doctorate in chemistry from Oxford University, as well as over 15 years’ experience in the patent profession.
Mike advises companies of all sizes, from start-ups to multinational pharmaceutical firms. In addition to offering traditional patent attorney services (such as preparation, filing, prosecution and maintenance of patent applications or advising in relation to intellectual property held by others), Mike also advises upon various forms of ‘regulatory’ IP that are available for marketed pharmaceutical products. Indeed, Mike has particular expertise in connection with Supplementary Protection Certificates (SPCs), a form of additional protection for marketed pharmaceutical and agrochemical products.
The approach of Park Grove IP is to aim to secure repeat orders by identifying, optimising and delivering the intellectual property strategy that will help its clients’ businesses to succeed. It also aims to achieve this by delivering individually tailored, high quality advice in a prompt and cost-effective manner.